I am a third-year student in the B.HSc Biomedical Sciences Specialization. I am leading the development of the genetic circuit to provide an self-regulating, in situ therapeutic option to prostate cancer. Outside of iGEM, I am working on a research project exploring the intersection between several neurodegenerative genes (ex. Setx, Ighmbp2) and the immune response using genetic engineering methods such as CRISPR.